APA (7th ed.) Citation

Haratani, K., Yonesaka, K., Takamura, S., Maenishi, O., Kato, R., Takegawa, N., . . . Nakagawa, K. (2020). U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation. The Journal of clinical investigation, 130(1), 374-388. https://doi.org/10.1172/JCI126598

Chicago Style (17th ed.) Citation

Haratani, Koji, et al. "U3-1402 Sensitizes HER3-expressing Tumors to PD-1 Blockade by Immune Activation." The Journal of Clinical Investigation 130, no. 1 (2020): 374-388. https://doi.org/10.1172/JCI126598.

MLA (9th ed.) Citation

Haratani, Koji, et al. "U3-1402 Sensitizes HER3-expressing Tumors to PD-1 Blockade by Immune Activation." The Journal of Clinical Investigation, vol. 130, no. 1, 2020, pp. 374-388, https://doi.org/10.1172/JCI126598.